Stericycle Company Profile (NASDAQ:SRCL)

Stericycle trades on the NASDAQ under the ticker symbol "SRCL."

Stericycle, Inc. (NASDAQ:SRCL) released its earnings results on Thursday, August, 3rd. The company reported $1.15 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.13 by $0.02. The company had revenue of $917.70 million for the quarter, compared to analysts' expectations of $902.81 million. Stericycle had a positive return on equity of 14.35% and a negative net margin of 0.07%. The business's revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.18 EPS. View Stericycle's Earnings History.

Stericycle is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Stericycle.

12 analysts have issued 1 year target prices for Stericycle's shares. Their predictions range from $10.00 to $108.00. On average, they anticipate Stericycle's share price to reach $80.91 in the next twelve months. View Analyst Ratings for Stericycle.

Here are some recent quotes from research analysts about Stericycle stock:

• 1. According to Zacks Investment Research, "Stericycle’s acquisition binge is leading to higher overheads and integration-related expenses, which are weighing on margins. Furthermore, many acquisitions have lower gross margins and higher selling, general and administrative expenses that often negate the positives. In addition, low barriers to entry in the industry and stiff competition from local as well as global players significantly reduce its price control. High operating costs also continue to be a headwind for Stericycle. Moreover, a challenging macroeconomic environment and volatility in foreign exchange are affecting the profitability. Evolving rules and regulations impose new compliance requirements and further erode margins. Stericycle underperformed the industry year to date. However, Stericycle has a competitive edge with the largest collection and transportation network in the industry, which allows it to compete effectively on both service and price perspectives." (10/4/2017)
• 2. Jefferies Group LLC analysts commented, "Even better than we were expecting and contrary to what was foreshadowed in the Jan 26 8-K, SRCL exceeded our 4Q EPS estimate by $0.05 (or 5%). The operational assumptions embedded in '17 guidance were also reaffirmed, though the mid-point of the range is $0.03 (or 1%) lower on a stronger FX headwind. Notably, the pricing resets are tracking as expected and the early pilot programs aimed at mitigating drag from future renewals are showing encouraging results." (2/16/2017)

Some companies that are related to Stericycle include Advanced Disposal Services (ADSW), Covanta Holding Corporation (CVA), US Ecology (ECOL), Renewi PLC (RWI), Casella Waste Systems (CWST), Biffa PLC (BIFF), Heritage-Crystal Clean (HCCI), Sharps Compliance Corp (SMED), Perma-Fix Environmental Services (PESI), Vertex Energy (VTNR), Augean plc (AUG), Marathon Patent Group (MARA) and Renewi PLC (SKS).

Stericycle's management team includes the folowing people:

• Mark C. Miller, Chairman of the Board
• Charles A. Alutto, President, Chief Executive Officer, Director
• Daniel V. Ginnetti, Chief Financial Officer, Executive Vice President
• Brent Arnold, Chief Operating Officer, Executive Vice President
• John P. Schetz, Executive Vice President, General Counsel
• Ruth-Ellen Abdulmassih, Executive Vice President and President, Communication & Related Services
• Michael J. Collins, Executive Vice President, President - Recall and Returns Management Services
• Brenda Frank, Executive Vice President, Chief People Officer
• Richard J. Hoffman, Senior Vice President, Chief Accounting Officer
• Jack W. Schuler, Lead Independent Director

Stericycle's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Eqis Capital Management Inc. (0.01%) and Fulton Bank N.A. (0.01%). Company insiders that own Stericycle stock include Daniel Ginnetti, John P Schetz, Mark C Miller, Mike S Zafirovski, Robert S Murley and Rodney F Dammeyer. View Institutional Ownership Trends for Stericycle.

Stericycle's stock was sold by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc.. View Insider Buying and Selling for Stericycle.

Stericycle's stock was purchased by a variety of institutional investors in the last quarter, including Fulton Bank N.A.. Company insiders that have bought Stericycle stock in the last two years include Mike S Zafirovski and Robert S Murley. View Insider Buying and Selling for Stericycle.

Shares of Stericycle can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Stericycle stock can currently be purchased for approximately $71.27.